3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained.

Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A, Tesei A. · 2016

Read 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. by Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A, Tesei A. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4707510.txt.

Introduction

Michele Zanoni, Filippo Piccinini, Chiara Arienti, and five colleagues studied reproducibility in 3D tumor spheroid testing, in Scientific Reports in 2016. Spheroids, balls of tumor cells with mixed growth states, promise more realistic drug screening than flat cell layers. Yet almost nothing was known about how repeatable spheroid data are. Using new open-source software that measures spheroid images automatically, the team hunted for sources of scatter in treatment responses.

Size and shape both mattered: large spheroids of uneven volume or outline answered treatments inconsistently. Comparing commercial viability tests built for 3D models, they picked and validated one that reports damage faithfully in spheroids up to a stated size. Their prescription is simple: pre-select spheroids of uniform volume and shape before any drug test. That discipline, they argue, is what will make 3D screening data worth trusting in drug development.

Catalog record

CREATORZanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, Bevilacqua A, Tesei A.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4707510

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained By Michele Zanoni, Filippo Piccinini, Chiara Arienti, Alice Zamagni, Spartaco Santi, Rolando Polico, Alessandro Bevilacqua, Anna Tesei Published in: Scientific Reports DOI: 10.1038/srep19103 ABSTRACT The potential of a spheroid tumor model composed of cells in different proliferative and metabolic states for the development of new anticancer strategies has been amply demonstrated. However, there is little or no information in the literature on the problems of reproducibility of data originating from experiments using 3D models. Our analyses, carried out using a novel open source software capable of performing an automatic image analysis of 3D tumor colonies, showed that a number of morphology parameters affect the response of large spheroids to treatment. In particular, we found that both spheroid volume and shape may be a source of variability. We also compared some commercially available viability assays specifically designed for 3D models. In conclusion, our data indicate the need for a pre-selection of tumor spheroids of homogeneous volume and shape to reduce data variability to a minimum before use in a cytotoxicity test. In addition, we identified and validated a cytotoxicity test capable of providing meaningful data on the damage induced in large tumor spheroids of up to diameter in 650 μm by different kinds of treatments. Chemotherapy, together with surgery and radiotherapy, is one of most common types of cancer treatment. Since its introduction, considerable efforts have been made by clinicians and researchers to optimize drug efficacy and minimize side-effects. In parallel, the pharmaceutical industry has increased investments into drug discovery programs to provide new molecules and biologic agents for clinical development and pharma market. However, the attrition rate for cancer drugs entering early clinical trials has reached disturbing heights1, suggesting that preclinical development has not been successful in identifying agents that can modify the outcome of human cancer2. Furthermore, there is also substantial inter-patient variability in response to new generation drugs, and research into personalized medicine focusing on the development of predictive biomarkers and preclinical cytotoxicity models has yet to provide satisfactory results. In the past, the in vitro screening of synthetic and natural product libraries for novel anticancer agents mainly relied on cytotoxicity assays using established cancer cell lines grown as two-dimensional (2D) cultures that exhibited a rapid, uncontrolled growth phenotype. Such an approach indisputably has several strengths and in the past has contributed significantly to increasing our knowledge of tumor biology and to stimulating research into the field of anticancer drug discovery and development. However, cytotoxicity assays based on 2D cell cultures show important limitations that may partially account for the high rate of clinical trial failures for new molecules notwithstanding excellent antitumor properties observed in both in vitro and in vivo preclinical testing34. In particular, conventional 2D cell cultures are not capable of mimicking the complexity and heterogeneity of clinical tumors as in vivo tumors grow in a three-dimensional (3D) conformation with a specific organization and architecture that a 2D monolayer cell culture cannot reproduce. Consequently, numerous signals that govern different cellular processes are lost when cells are grown in 2D plastic substrata5. Three-dimensional (3D) growth of immortalized established cell lines or primary cell cultures is regarded as a more stringent and representative model on which to perform in vitro drug screening6. As reported in detail by Kimlin et al.7, 3D cell cultures possess several in vivo features of tumors such as cell-cell interaction8, hypoxia9, drug penetration10, response and resistance9, and production/deposition of extracellular matrix7. All of these factors shift growth dependence away from the phenotype of unrestrained proliferation which is dominant in standard 2D cultures. Furthermore, the study of cancer cell dynamics in a 3D context allows us to recapitulate the architecture of living tissue and to better investigate the pathobiology of human cancers11. It is now common opinion that in vitro 3D cultures could fill the gap between conventional 2D in vitro testing and animal models12, and many researchers recommend the use of 3D cell cultures in drug screening programs as support for conventional 2D monolayer studies and before activating animal protocols1314. Several types of 3D culture models have been developed. These are generally subdivided into liquid-based and scaffold-based 3D-models6. Scaffold platforms for 3D culture are made of synthetic or naturally-derived polymers that provide a support for cell growth and mimic extracellular matrix conditions. Currently available scaffolds often show difficulties in obtaining a controlled matrix15 that can support the cellular physiologic growth and interaction profile found in vivo14. Tumor spheroids are one of the most common and versatile scaffold-free methods for 3D cell culture. Spheroids are either self-assembling or are forced to grow as cell clusters starting from single cell suspensions12. Compared to cells cultured on a flat surface, they more closely mimic the complex scenario of tissues and organs where each cell interacts with nearby cells through the formation of desmosomes and dermal junctions16. Depending on the researcher’s needs and on the method used, it is possible to obtain spheroids of any dimension. In particular, large spheroids (starting from about 500 μm in diameter) are characterized by an external proliferating zone, an internal quiescent zone caused by limited distribution of oxygen, nutrients and metabolites, and a necrotic core17 resembling the cellular heterogeneity of solid in vivo tumors18192021. The potential of spheroid models for the development of new anticancer strategies has been demonstrated over time1222. Chemo- and radio-cytotoxicity are the most important areas of use for large spheroids23 as the clinical response to chemical or physical treatments also depends on parameters such as oxygen tension, compactness, apoptosis inhibition24, damage repair25, and permeability26. However, in addition to the fact that not all available methods produce an abundance of large tumor spheroids, the use of this model, composed of cells in different proliferative and metabolic states, has raised serious concerns about the reproducibility of data produced. Moreover, the method used to assess treatment effectiveness may be a source of variability as the conventional methods developed for 2D cultures27 are not suitable for 3D models28. The lack of a reference method has stimulated the development of new assays specifically designed for 3D models that appear to be more promising than the Trypan blue exclusion test, still the most widely used cytotoxicity test in this research field28. In the present work we used AnaSP, a software suite written in MATLAB (©, The MathWorks, Inc., Natick, MA, USA) and distributed as an open-source tool at http://sourceforge.net/p/anasp/ 29. AnaSP was previously developed by our team to automatically analyze several morphological parameters of spheroids imaged with entry-level equipment such as a standard brightfield microscope. Our first goal was to show that spheroids heterogeneous in volume and shape constitute a potential source of variability and may respond differently to treatments. We would thus propose an approach based on spheroid pre-selection to obtain reproducible results using large spheroids (Fig. 1). Finally, we validated a viability assay capable of providing rigorous data about cytotoxic effects on spheroids of up to 650 μm in diameter. RESULTS Comparison between different methods for producing large tumor spheroids Before starting the analysis it is worth introducing the notion of “equivalent diameter”, needed in the presence of a non-perfect sphericity, and

Read the complete text